Abstract
There is growing evidence that migraine is associated with attentional abnormalities, both during and outside migraine attacks, which would impact the cognitive processing of sensory stimulation. However, these attention alterations are poorly characterized and their neurophysiological basis is still unclear. Nineteen migraineurs without aura and nineteen healthy participants were recruited to perform a task which used visually-cued auditory targets and distracting sounds to evaluate conjointly top-down and bottom-up attention mechanisms. Magnetoencephalography (MEG) signals were recorded. We investigated anticipatory alpha activity (power increase and decrease) and distractor-induced gamma activity as markers for top-down (inhibition and facilitation) and bottom-up attention, respectively. Compared to healthy participants, migraineurs presented a significantly less prominent alpha power increase in visual areas in anticipation of the auditory target, indexing a reduced inhibition of task-irrelevant visual areas. However, there was no significant group difference regarding the alpha power decrease in the relevant auditory cortices in anticipation of the target, nor regarding the distractor-induced gamma power increase in the ventral attention network. These results in the alpha band suggest that top-down inhibitory processes in the visual cortices are deficient in migraine but there is no clear evidence supporting a disruption of top-down facilitatory attentional processes. This relative inability to suppress irrelevant sensory information may be underlying the self-reported increased distractibility and contribute to sensory disturbances in migraine.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02791997
Funding Statement
This work was supported by the French National Research Agency (ANR) Grant ANR-14-CE30-0001-01 (to Aurélie Bidet-Caulet and Anne Caclin). This work was performed within the framework of the LABEX CORTEX (ANR-11-LABX-0042) and the LABEX CeLyA (ANR-10-LABX-0060) of Université de Lyon, within the program ′Investissements d′Avenir′ (ANR-16-IDEX-0005) operated by the French ANR.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval of this work was obtained through the Hospices Civils de Lyon, approved by the local ethical committee (Comité de Protection des Personnes SUD EST III). Therefore, this work has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures:This work was supported by the French National Research Agency (ANR) Grant ANR-14-CE30-0001-01 (to Aurélie Bidet-Caulet and Anne Caclin). This work was performed within the framework of the LABEX CORTEX (ANR-11-LABX-0042) and the LABEX CeLyA (ANR-10-LABX-0060) of Université de Lyon, within the program “Investissements d’Avenir” (ANR-16-IDEX-0005) operated by the French ANR. The ethical approval of this work was obtained through the Hospices Civils de Lyon. The authors declare that there is no conflict of interest regarding the subject matter of this article.
Trial registration:The study was approved by the regional ethical committee (Comité de Protection des Personnes SUD EST III) and registered under the ID number NCT02791997.
Data Availability
The data that support the findings of this study are not publically available as participants did not consent to data sharing
